Introduction Autism and dyslexia are both neurodevelopmental disorders that significantly impact individuals' cognitive and social capabilities
M., Mieszczanek, J., Fiedler, M., Rutherford, T
Brady S, Cunningham S, Brubaker L, Falke C, James A, Kenton K, Low L, Markland A, Mcgwin G, Newman D, Norton J, Nuscis K, Rodriguez-Ponciano D, Rudser K, Smith A, Stapleton A, Sutcliffe S, Klusaritz H, Brubaker L, Fitzgerald C, Acevedo-Alvarez M, Hardacker C, Hebert-Beirne J, Griffith J, Kenton K, Simon M, Brown O, Geynisman-Tan J, Mueller M, Markland A, Vaughan C, Coyne-Beasley T, Burgio K, Lewis C, McGwin G, Williams B, Lukacz E, LaCoursiere D, Gahagan S, Nodora J, Low L, Miller J, Smith A, McGwin G, Rudser K, Brady S, Fok C, Harlow B, Rockwood T, Scal P, Newman D, Smith A, Berry A, Bilger A, Klusaritz H, Lipman T, Stapleton A, Wyman J, Sutcliffe S, James A, Lowder J, Meister M, Rickey L, Camenga D , Cunningham S, Brubaker L, Norton J
While the FDA is not required to follow the panel's recommendations, it often does